Pacira names Lauren Riker interim CFO; Reinhart departs Sept 30

Pacira BioSciences, Inc.

CFO Charles Reinhart departs Sept 30, 2024; will serve as consultant for 9 months.
Lauren Riker, SVP of Finance, appointed interim CFO effective Oct 1, 2024.
Riker's base salary unchanged at $374,700; bonus target 50%; receives one-time $75k bonus.
Riker to serve as interim CFO until permanent successor identified.
No changes to existing employment agreement or other compensation terms.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles A. Reinhart, III

Chief Financial Officer

PCRX · Pacira BioSciences, Inc.

Effective: 2024-09-30
Successor: Lauren Riker
Filed: September 27, 2024, 7:59 PM ET

Charles A. Reinhart, III, the Company’s Chief Financial Officer, agreed that he would depart the Company effective September 30, 2024, and will continue to serve as consultant to the Company for a period of nine months thereafter.

Appointed (interim)

Lauren Riker

interim Chief Financial Officer

PCRX · Pacira BioSciences, Inc.

Effective: 2024-10-01
Filed: September 27, 2024, 7:59 PM ET

On September 26, 2024, the Board of Directors of the Company (the “Board”) appointed Lauren Riker, the Company’s current Senior Vice President of Finance and principal accounting officer, to also serve as interim Chief Financial Officer of the Company (including as principal financial officer and continuing as principal accounting officer for Securities and Exchange Commission reporting purposes), effective October 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles A. Reinhart, III departed as Chief Financial Officer at Pacira BioSciences, Inc..

Action: depart
Role: Chief Financial Officer

Exact text from the filing

Charles A. Reinhart, III, the Company’s Chief Financial Officer, agreed that he would depart the Company effective September 30, 2024, and will continue to serve as consultant to the Company for a period of nine months thereafter.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lauren Riker was appointed as interim Chief Financial Officer at Pacira BioSciences, Inc..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

On September 26, 2024, the Board of Directors of the Company (the “Board”) appointed Lauren Riker, the Company’s current Senior Vice President of Finance and principal accounting officer, to also serve as interim Chief Financial Officer of the Company (including as principal financial officer and continuing as principal accounting officer for Securities and Exchange Commission reporting purposes), effective October 1, 2024.

View on SEC.gov

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-24-000124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.